Evaluation of the Inclusion of Studies Identified by the FDA as Having Falsified Data in the Results of Meta-analyses: The Example of the Apixaban Trials Letter

cited authors

  • Garmendia, Craig A.; Gorra, Liliana Nassar; Rodriguez, Ana Lucia; Trepka, Mary Jo; Veledar, Emir; Madhivanan, Purnima

publication date

  • April 1, 2019

webpage

published in

category

Digital Object Identifier (DOI)

start page

  • 582

end page

  • 584

volume

  • 179

issue

  • 4